|Screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics: a quality improvement programme.|
|PMID: 18582345 Owner: NLM Status: MEDLINE|
|OBJECTIVE: The aim was to evaluate a quality improvement programme designed to increase screening for the metabolic syndrome in community psychiatric patients prescribed antipsychotics. METHOD: Baseline audit against evidence-based standards, followed by provision of benchmarked data and a range of change interventions, with re-audit 1 year later. RESULTS: At baseline, 48 assertive outreach teams across the UK submitted data on screening over the previous year for 1966 patients. At re-audit, 35 of the teams submitted data for 1516 patients. Screening for all four aspects of the metabolic syndrome (measuring blood pressure, obesity, blood glucose and plasma lipids) had increased significantly by re-audit. Clinical variables increasing the likelihood of full screening were clozapine treatment and a known diagnosis of diabetes or dyslipidaemia. CONCLUSION: The programme's success may be partly attributed to the use of a widely-accepted audit standard, and bespoke change interventions that directly addressed barriers to screening identified by the participating clinical teams.|
|T R E Barnes; C Paton; E Hancock; M-R Cavanagh; D Taylor; P Lelliott;|
Related Documents :
|23435955 - Intergenerational programming of metabolic disease: evidence from human populations and...
24630175 - Exploring the relationship between cognitive illness representations and poor emotional...
23877985 - New-onset diabetes mellitus in elderly subjects: association between hba1c levels, mort...
24872385 - The impact of diabetes self-management education on glucose management and empowerment ...
18057795 - effect of propolis on insulin resistance in fructose-drinking rats
2351025 - Lack of relationship between glucose tolerance and complications of pregnancy in nondia...
|Type: Journal Article; Research Support, Non-U.S. Gov't|
|Title: Acta psychiatrica Scandinavica Volume: 118 ISSN: 1600-0447 ISO Abbreviation: Acta Psychiatr Scand Publication Date: 2008 Jul|
|Created Date: 2008-06-27 Completed Date: 2008-09-25 Revised Date: -|
Medline Journal Info:
|Nlm Unique ID: 0370364 Medline TA: Acta Psychiatr Scand Country: Denmark|
|Languages: eng Pagination: 26-33 Citation Subset: IM|
|Department of Psychological Medicine, Imperial College Faculty of Medicine, Charing Cross Campus, London, UK. firstname.lastname@example.org|
|APA/MLA Format Download EndNote Download BibTex|
Antipsychotic Agents / adverse effects*, therapeutic use
Benchmarking / standards
Body Weight / drug effects
Community Mental Health Services / standards
Community-Institutional Relations / standards
Dose-Response Relationship, Drug
Drug Therapy, Combination
Health Services Accessibility
Mass Screening / standards*
Medical Audit / standards
Metabolic Syndrome X / chemically induced*, diagnosis, epidemiology
Mood Disorders / drug therapy*, epidemiology
Psychotic Disorders / drug therapy*, epidemiology
Quality Assurance, Health Care / standards*
Quality Indicators, Health Care / standards
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Body mass index and prevalence of obesity in a French cohort of patients with schizophrenia.
Next Document: Sequences of emotions in patients with borderline personality disorder.